ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J. M.
Right arrow Articles by Knowles, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J. M.
Right arrow Articles by Knowles, D. M.

The Annals of Thoracic Surgery, Vol 56, 527-538, Copyright © 1993 by The Society of Thoracic Surgeons

ARTICLES

Management of lymphoproliferative disorders after cardiac transplantation

JM Chen, ML Barr, A Chadburn, G Frizzera, FA Schenkel, RR Sciacca, DS Reison, LJ Addonizio, EA Rose and DM Knowles
Department of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032.

We conducted a retrospective study of 516 cardiac recipients who underwent transplantation between April 1983 and April 1992, 19 of whom had development of post-transplantation lymphoproliferative disorders (PTLDs). These 19 patients presented with involvement of lung (5), gastrointestinal tract (5), disseminated disease (6), and adenoids and lymph nodes (3). B-cell proliferations ranging from an atypical hyperplasia to malignant lymphoma developed in 18 patients, and mixed cellularity Hodgkin's disease developed in 1 patient. The 19 patients with PTLD displayed a predominance of both women and cardiomyopathy as the indication for transplantation when compared with two separate control populations. No correlation was found between demographic criteria analyzed and (1) early versus late diagnosis of PTLD after transplantation, (2) the site of PTLD involvement, or (3) the histopathologic category of the PTLD lesion. Patients with gastrointestinal tract and lung PTLD involvement enjoyed an improved survival after both transplantation and PTLD diagnosis when compared with patients with PTLD involvement of all other extranodal sites. We report a high incidence of PTLD involving the lung and gastrointestinal tract in our cohort study. These sites of involvement responded better to a reduction in immunosuppression than did the other extranodal sites of involvement.


This article has been cited by other articles:


Home page
 ChestHome page
R. Lenner, M. L. Padilla, A. S. Teirstein, A. Gass, and G. J. Schilero
Pulmonary Complications in Cardiac Transplant Recipients
Chest, August 1, 2001; 120(2): 508 - 513.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Setsuda, J. Teruya-Feldstein, N. L. Harris, J. A. Ferry, L. Sorbara, G. Gupta, E. S. Jaffe, and G. Tosato
Interleukin-18, Interferon-{gamma}, IP-10, and Mig Expression in Epstein-Barr Virus-Induced Infectious Mononucleosis and Posttransplant Lymphoproliferative Disease
Am. J. Pathol., July 1, 1999; 155(1): 257 - 265.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. J. Goldstein, D. L. Williams, M. C. Oz, A. D. Weinberg, E. A. Rose, and R. E. Michler
De Novo Solid Malignancies After Cardiac Transplantation
Ann. Thorac. Surg., December 1, 1995; 60(6): 1783 - 1789.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.